Status:
UNKNOWN
Viennese Prevalence Study of Anderson-Fabry Disease
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Medical University of Graz
Conditions:
Fabry Disease
Left Ventricular Hypertrophy
Eligibility:
All Genders
18-90 years
Brief Summary
The prevalence of Anderson - Fabry disease in patients with left ventricular hypertrophy is unclear. The investigators will examine urine - α - Galactosidase activity and globotriaosylceramide isoform...
Detailed Description
Anderson - Fabry disease (AFD) is a rare, X - linked hereditary systemic lysosomal storage disorder which usually affects the heart. The reported incidence of AFD is between 1 in 117000 and 1 in 24000...
Eligibility Criteria
Inclusion
- Patients with myocardial septum wall thickness ≥ 12mm
Exclusion
- Patients \< 18 years
- Patients unable to provide urine sample
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2012
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00871611
Start Date
January 1 2009
End Date
January 1 2012
Last Update
July 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine II, Div. Cardiology, Vienna General Hospital
Vienna, Austria, 1090